[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Chuncheon Sacred Heart Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":159},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,7,0,[8,45,69,89,112,129,143],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100516193","efficacy-and-safety-of-fmt-for-the-decolonization-of-mdros-in-the-intestinal-tract-100516193",false,"NCT06001333","Efficacy and Safety of FMT for the Decolonization of MDROs in the Intestinal Tract","Efficacy and Safety of Fecal Microbiota Transplantation for the Decolonization of Multidrug-Resistant Organisms in the Intestinal Tract: An Unblinded Randomized Controlled Trial","Inclusion Criteria:\n\n1. Individuals aged 20 and older.\n2. Those with confirmed carbapenemase-producing Enterobacteriaceae (CPE) from a rectal swab culture within the past week (class A, B, or D CPE).\n3. Those with confirmed vancomycin-resistant Enterococci (E. fecalis or E. faecium) from a rectal swab culture within the past week.\n4. Individuals who have agreed to undergo Fecal Microbiota Transplantation (FMT) procedures and to provide pre- and post-procedure stool samples.\n5. Individuals who have discontinued antibiotics for a period of 3 to 7 days prior to FMT procedure.\n\nExclusion Criteria:\n\n1. Patients with ongoing or anticipated acute treatment, including antibiotic therapy.\n2. Individuals with severe immunodeficiency.\n3. Cases where there is a risk due to upper gastrointestinal endoscopy or colonoscopy.\n4. Pregnant individuals, those who could become pregnant, and breastfeeding women.\n5. Cases where participation in the study is determined by the researcher not to be beneficial.","ALL","20 Years",{"count":19,"type":20},240,"ESTIMATED","INTERVENTIONAL",[23],"NA","The goal of this unblinded randomized controlled trial is to evaluate the efficacy and safety of fecal microbiota transplantation for the decolonization of carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE) or vancomycin-resistant Enterococci (VRE) in the intestinal tract. The study is planned to be conducted to test the superiority hypothesis that the decolonization success rate in the FMT group is higher compared to the non-FMT group. Outcome analysis will be conducted through intention-to-treat analysis, modified intention-to-treat analysis, and per-protocol analysis.\n\nThe main questions it aims to answer are:\n\n* primary endpoint: Rate of Decolonization of Multidrug-Resistant Organisms (CP-CRE or VRE) at 1 Month After Fecal Microbiota Transplantation (FMT).\n* secondary endpoint: Rates of Multidrug-Resistant Organism decolonization at 3 months, 6 months, and 1 year after FMT \u002F Post-FMT Multidrug-Resistant Organism Recolonization Rate and Infection Rate.\n\nPatients colonized with multidrug-resistant organisms in the gastrointestinal tract are divided into two groups through obtaining written consent from the patients and random allocation: the Fecal Microbiota Transplantation group (FMT group), which receives FMT, and the control group (non-FMT group), which is observed without FMT. The decolonization status of multidrug-resistant organisms will be monitored every 3-7 days after FMT until three consecutive negative results.",[26,27],"Carbapenem-Resistant Enterobacteriaceae","Vancomycin (Glycopeptide) Resistant Enterococcus (VRE)",[26,29,30,31],"Vancomycin-Resistant Enterococci","Fecal Microbiota Transplantation","Gastrointestinal Microbiome","RECRUITING","2025-06-16",{"date":35,"type":36},"2025-06-19","ACTUAL",{"date":38,"type":36},"2023-09-18",{"date":40,"type":20},"2026-12-31",{"name":42,"class":43},"Chuncheon Sacred Heart Hospital","OTHER",2,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":52,"targetDuration":4,"studyType":21,"phases":54,"briefSummary":55,"conditions":56,"keywords":4,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},"100593037","scapular-dyskinesis-with-impingement-syndrome-100593037","NCT07001228","Scapular Dyskinesis With Impingement Syndrome","Diagnosis and Treatment of Scapular Dyskinesis Combined With Impingement Syndrome of Shoulder","1. Inclusion Criteria\n\n   Patients diagnosed with unilateral shoulder impingement syndrome in the outpatient clinic (based on clinical symptoms and MRI) from the IRB approval date until March 1, 2027\n\n   Individuals who provided written informed consent after receiving a thorough explanation of the study prior to any procedures\n\n   Age 20 years or older\n2. Exclusion Criteria\n\nIndividuals who did not receive a subacromial steroid injection for shoulder impingement syndrome\n\nIndividuals with a history of surgical treatment or fracture in the affected shoulder\n\nIndividuals who refused to participate in the study\n\nIndividuals with neurological disorders affecting the ipsilateral upper extremity",{"count":53,"type":20},360,[23],"The goal of this study is to diagnose scapular dyskinesis-which can appear as a cause or result of various shoulder disorders-through screening tests in patients with shoulder impingement syndrome, the most common shoulder condition. By identifying scapular dyskinesis, the study aims to maximize treatment outcomes through appropriate rehabilitative exercise therapy.",[57,58],"Scapular Dyskinesis","Impingement Syndrome, Shoulder","NOT_YET_RECRUITING","2025-06-04",{"date":62,"type":36},"2025-06-06",{"date":64,"type":20},"2025-05-29",{"date":66,"type":20},"2027-05-31",{"name":42,"class":43},1,{"id":70,"slug":71,"hasResults":11,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":4,"eligibilityCriteria":75,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":76,"targetDuration":4,"studyType":21,"phases":78,"briefSummary":79,"conditions":80,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":44},"100583597","isb-with-ssnb--anb-100583597","NCT06878391","ISB With SSNB & ANB","A Study on the Pain Control Effects of Interscalene Brachial Plexus Block Combined With Suprascapular Nerve Block and Axillary Nerve Block in Ar-throscopic Rotator Cuff Repair: a Randomized Controlled Trial","Inclusion Criteria:\n\n* a definite rotator cuff tear that needed repair seen on preoperative magnetic resonancce imaging (MRI)\n* acceptance of arthroscopic surgery including rotator cuff repair\n* age same as or more than 20 years\n* acceptance of preemptive regional block and PCA, and blood testing\n\nExclusion Criteria:\n\n* did not undergo arthroscopic rotator cuff repair\n* stopped PCA before 48 hours postoperatively because of associated side effects\n* a history of previous ipsilateral shoulder operation or fracture\n* a concomitant neurologic disorder around the shoulder\n* a failure of blood sampling including hemolysis, etc.",{"count":77,"type":20},100,[23],"This study is a prospective, randomized, double-blind trial comparing patients who underwent arthroscopic rotator cuff repair and received an interscalene brachial plexus block (9 ml of 0.75% ropivacaine, 3 ml for each trunk) combined with suprascapular nerve block and axillary nerve block (each with 10 ml of 0.75% ropivacaine) versus those who received an interscalene brachial plexus block (9 ml of 0.75% ropivacaine, 3 ml for each trunk) combined with placebo suprascapular and axillary nerve blocks (each with 10 ml of 0.9% saline).\n\nThe study will compare subjective pain scores (VAS score) and patient satisfaction preoperatively and at 1, 3, 6, 12, 18, 24, 36, and 48 hours postoperatively. Additionally, 5 ml of venous blood will be collected preoperatively and at 1, 6, 12, 24, and 48 hours postoperatively to analyze and compare serum levels of cortisol, IL-6, IL-8, IL-1β, substance P, serotonin, β-endorphin, and norepinephrine.",[81],"Rotator Cuff Tear","2025-05-23",{"date":64,"type":36},{"date":85,"type":36},"2025-03-24",{"date":87,"type":20},"2027-01-31",{"name":42,"class":43},{"id":90,"slug":91,"hasResults":11,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":4,"eligibilityCriteria":95,"healthyVolunteers":11,"sex":16,"minAge":96,"maxAge":97,"enrollmentInfo":98,"targetDuration":4,"studyType":21,"phases":99,"briefSummary":100,"conditions":101,"keywords":104,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":106,"startDateStruct":108,"completionDateStruct":109,"leadSponsor":111,"locationsCount":68},"100519806","fnb-in-meniscal-tear-under-sa-100519806","NCT06048341","FNB in Meniscal Tear Under SA","Effects of Sono-guided Femoral Nerve Block in Arthroscopic Surgery for Meniscal Tear Under Spinal Anesthesia: A Randomized Controlled Trial","Inclsuion Criteria:\n\n* individuals who are scheduled to undergo meniscal surgery and must be received sufficient explanation about the research prior to surgery and have provided their informed consent to participate.\n\nExclusion Criteria:\n\n* who require simultaneous surgery for concomitant cartilage injury, collateral ligament tear.\n* who have previously undergone surgical treatment within the knee joint.\n* who have declined to participate in the research.\n* where medical, surgical, or anesthetic complications occurred during surgery.\n* other cases deemed necessary by the researchers.","19 Years","60 Years",{"count":77,"type":20},[23],"The investigators will compare the results of sono-guided femoral nerve block in arthroscopic surgery for meniscal tear under spinal anesthesia",[102,103],"Meniscus Tear","Femoral Nerve Block",[102,103],"2023-09-20",{"date":107,"type":36},"2023-09-22",{"date":38,"type":20},{"date":110,"type":20},"2026-09-18",{"name":42,"class":43},{"id":113,"slug":114,"hasResults":11,"nctId":115,"briefTitle":116,"officialTitle":117,"acronym":4,"eligibilityCriteria":118,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":119,"targetDuration":4,"studyType":21,"phases":120,"briefSummary":121,"conditions":122,"keywords":4,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":124,"startDateStruct":125,"completionDateStruct":126,"leadSponsor":128,"locationsCount":68},"100519845","fnb-in-acl-recon-under-ga-100519845","NCT06048848","FNB in ACL Recon Under GA","Effects of Sono-guided Femoral Nerve Block in Arthroscopic Surgery for Anterior Cruciate Reconstruction Under General Anesthesia: A Randomized Controlled Trial","Inclusion Criteria:\n\n* individuals who are scheduled to undergo arthroscopic anterior cruciate ligament reconstruction surgery and must be received sufficient explanation about the research prior to surgery and have provided their informed consent to participate.\n\nExclusion Criteria:\n\n* who require simultaneous surgery for concomitant cartilage injury, medial meniscus tear, and lateral collateral ligament tear.\n* who have previously undergone surgical treatment within the knee joint.\n* who have declined to participate in the research.\n* where medical, surgical, or anesthetic complications occurred during surgery.\n* other cases deemed necessary by the researchers.",{"count":77,"type":20},[23],"The investigators will compare the results of sono-guided femoral nerve block in arthroscopic surgery for anterior cruciate ligament reconstruction under general anesthesia.",[123,103],"Anterior Cruciate Ligament Rupture",{"date":107,"type":36},{"date":38,"type":20},{"date":127,"type":20},"2028-09-18",{"name":42,"class":43},{"id":130,"slug":131,"hasResults":11,"nctId":132,"briefTitle":133,"officialTitle":134,"acronym":4,"eligibilityCriteria":118,"healthyVolunteers":11,"sex":16,"minAge":96,"maxAge":97,"enrollmentInfo":135,"targetDuration":4,"studyType":21,"phases":136,"briefSummary":137,"conditions":138,"keywords":4,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":139,"startDateStruct":140,"completionDateStruct":141,"leadSponsor":142,"locationsCount":68},"100519847","fnb-in-acl-recon-under-sa-100519847","NCT06048874","FNB in ACL Recon Under SA","Effects of Sono-guided Femoral Nerve Block in Arthroscopic Surgery for Anterior Cruciate Reconstruction Under Spinal Anesthesia: A Randomized Controlled Trial",{"count":77,"type":20},[23],"The investigators will compare the results of sono-guided femoral nerve block in arthroscopic surgery for anterior cruciate ligament reconstruction under spinal anesthesia.",[123,103],{"date":107,"type":36},{"date":38,"type":20},{"date":127,"type":20},{"name":42,"class":43},{"id":144,"slug":145,"hasResults":11,"nctId":146,"briefTitle":147,"officialTitle":148,"acronym":4,"eligibilityCriteria":149,"healthyVolunteers":11,"sex":16,"minAge":96,"maxAge":97,"enrollmentInfo":150,"targetDuration":4,"studyType":21,"phases":151,"briefSummary":152,"conditions":153,"keywords":154,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":155,"startDateStruct":156,"completionDateStruct":157,"leadSponsor":158,"locationsCount":68},"100519617","fnb-in-meniscal-tear-under-ga-100519617","NCT06045884","FNB in Meniscal Tear Under GA","Effects of Sono-guided Femoral Nerve Block in Arthroscopic Surgery for Meniscal Tear Under General Anesthesia: A Randomized Controlled Trial","Inclusion Criteria:\n\n\\- individuals who are scheduled to undergo meniscal surgery and must be received sufficient explanation about the research prior to surgery and have provided their informed consent to participate.\n\nExclusion Criteria:\n\n* who require simultaneous surgery for concomitant cartilage injury, collateral ligament tear.\n* who have previously undergone surgical treatment within the knee joint.\n* who have declined to participate in the research.\n* where medical, surgical, or anesthetic complications occurred during surgery.\n* other cases deemed necessary by the researchers.",{"count":77,"type":20},[23],"The investigators will compare the results of sono-guided femoral nerve block in arthroscopic surgery for meniscal tear under general anesthesia",[102,103],[103,102],{"date":107,"type":36},{"date":38,"type":20},{"date":110,"type":20},{"name":42,"class":43},""]